USP13 and ovarian carcinoma: The mutation of the Thr122 phosphorylation site of USP13 reduced the proliferation of ovarian cancer cells compared with USP13 wild-type, suggesting that Thr122 phosphorylation is important for the oncogenic function of USP13 in ovarian cancer (Figure 7).